CONCORDBIO — Concord Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Concord Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,019	1,628	1,804	2,817	3,354
Net Total Accounts Receivable
Net Total Receivables	2,311	2,602	3,231	3,789	5,475
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,071	6,327	7,277	8,962	11,352
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,577	6,436	7,655	7,865	8,442
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11,825	13,128	15,140	17,007	20,343
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,057	1,552	1,918	1,422	1,841
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,832	2,096	2,240	1,741	2,215
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	9,994	11,032	12,900	15,266	18,127
Total Liabilities & Shareholders' Equity	11,825	13,128	15,140	17,007	20,343
Total Common Shares Outstanding